newsfilter
← Latest News
Business Wire·

Kiromic BioPharma Adds UPMC as Fourth Deltacel-01 Clinical Trial Site

Kiromic BioPharma, Inc. (OTCQB:KRBP) ("Kiromic" or the "Company") announces that UPMC in Pittsburgh, Pennsylvania has been activated as the fourth clinical trial site in the Deltacel-01 Phase 1 trial evaluating